Accolade, Inc. (ACCD)

Personalized health and benefits solutions provider offering advocacy and navigation services.

ACCD Stock Quote

Company Report

Accolade, Inc., based in Plymouth Meeting, Pennsylvania, is a pioneering provider of technology-driven solutions designed to empower individuals in navigating and optimizing their healthcare and workplace benefits within the United States. The company's integrated platform leverages cloud-based technology alongside personalized support from a dedicated team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. This multimodal approach ensures comprehensive assistance for understanding and utilizing healthcare resources effectively.

Central to Accolade's offerings are second opinion consultations and healthcare decision support services, enhancing the accessibility and quality of medical advice and treatment options available to users. The company primarily serves employers seeking to streamline and enhance their employees' access to healthcare services and benefits through a centralized and user-friendly interface.

Founded in 2007, Accolade has established itself as a leader in the healthcare navigation space, emphasizing personalized guidance and holistic support for individuals and families navigating complex healthcare systems. The company's innovative approach not only simplifies healthcare management but also improves outcomes by facilitating informed decisions and proactive health management strategies.

Accolade continues to expand its influence and capabilities, driven by its commitment to innovation and customer-centric service delivery. By inttegrating advanced technology with human expertise, Accolade aims to transform the healthcare experience, making it more accessible, understandable, and effective for its clients and their employees across the nation.

ACCD EPS Chart

ACCD Revenue Chart

Stock Research

SF AMGN SUN RVT COST ALVR UAA

ACCD Chart

View interactive chart for ACCD

ACCD Profile

ACCD News

Analyst Ratings